Table 2 Cox regression analysis of biochemical recurrence-free survival in ISUP grade 2 prostate cancer patients without lymph node metastasis at time of operation (n = 408)
Univariate analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 0.99 | 0.96–1.03 | 0.56 | 0.99 | 0.95–1.03 | 0.57 |
PSA | 1.02 | 1.01–1.04 | <0.001 | 1.01 | 0.99–1.02 | 0.34 |
pT-stage | ||||||
T2 | ||||||
T3a | 2.00 | 1.27–3.14 | 0.003 | 1.64 | 1.02–2.63 | 0.04 |
T3b | 4.42 | 2.24–8.72 | <0.001 | 3.00 | 1.42–6.34 | 0.004 |
Positive surgical margin | 3.24 | 2.11–4.97 | <0.001 | 3.28 | 2.06–5.23 | <0.001 |
Percentage Gleason 4 | 1.26 | 0.82–1.93 | 0.29 | 0.94 | 0.59–1.51 | 0.80 |
Tertiary Gleason 5 | 1.29 | 0.66–2.50 | 0.46 | 0.95 | 0.44–2.06 | 0.90 |
IDC-P | 2.13 | 1.36–3.36 | 0.001 | 1.32 | 0.77–2.25 | 0.31 |
Invasive cribriform | ||||||
Small | 1.50 | 0.95–2.37 | 0.09 | 1.07 | 0.65–1.75 | 0.80 |
Large | 3.98 | 2.10–7.57 | <0.001 | 4.36 | 2.08–9.17 | <0.001 |